Boston Common Asset Management, LLC Zoetis Inc. Transaction History

Boston Common Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$167.14 - $192.77 $20,056 - $23,132	-120 Reduced 9.13%	1,195 $208,000
Q2 2023 Jul 24, 2023	BUY	$160.94 - $186.23 $15,289 - $17,691	95 Added 7.79%	1,315 $226,000
Q1 2023 May 17, 2023	BUY	$145.48 - $175.02 $177,485 - $213,524	1,220 New	1,220 $203,000
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $226,737 - $292,537	1,250 New	1,250 $235,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Common Asset Management, LLC with notifications on news.